Nicholas A. Butowski

MD

Neuro-oncologist
Avid football – also known as soccer – fan

Dr. Nicholas Butowski is a neuro-oncologist who specializes in brain tumors, neuroimaging, cognitive and rehabilitative neurology, and complementary therapies for neurological disorders. He is director of clinical services in neuro-oncology and a researcher at the Brain Tumor Center.

In his research, Butowski focuses on developing treatments for primary brain tumors as well as methods to ensure good quality of life for patients and to assist them in recovering from or coping with brain injury.

Butowski earned his medical degree at the University of Illinois at Chicago. He completed a residency in neurology and a fellowship in neuro-oncology at UCSF. He is a member of the American Academy of Neurology, American Society of Clinical Oncology and Society for Neuro-oncology.

  • Education

    University of Illinois College of Medicine, 1999

  • Residencies

    UCSF Medical Center, Neurology, 2003

  • Fellowships

    UCSF Medical Center, Neuro-oncology, 2004

  • Academic Title

    Professor

Compassion is not a virtue; it is a commitment.

Where I see patients (1)

    My reviews

    4.9

    Overall Experience
    131 Ratings
    Explained things in a way that was easy to understand
    129 Ratings
    Did the doctor pay attention to your concerns
    129 Ratings
    Gave easy to understand instructions about taking care of health problems or concerns
    123 Ratings
    Knew the important information about your medical history
    130 Ratings
    The provider showed respect for what you had to say
    128 Ratings
    The provider spent enough time with me
    127 Ratings
    Decorative Caduceus

    Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & ...

    Survival will be measured from the time of randomization until date patient is alive.

    Recruiting

    Decorative Caduceus

    A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

    To assess the effect of berubicin compared with lomustine on overall survival (OS) in adult patients with GBM (WHO Grade IV) that has recurred after standard initial therapy

    Recruiting

    Decorative Caduceus

    3D Prediction of Patient-Specific Response

    Compare Assay results to reported patient outcomes

    Recruiting

    Decorative Caduceus

    A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

    Overall survival is defined from the time of randomization to death from any cause. Patients still alive at the time of an analysis will be considered censored at their date of last contact.

    Recruiting

    Decorative Caduceus

    A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

    Number of Participants with a Dose-Limiting Toxicity (DLT)

    Recruiting

    Decorative Caduceus

    A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurr...

    Recruiting

    Decorative Caduceus

    ONC201 in Adults With Recurrent H3 K27M-mutant Glioma

    Best overall response rate by RANO

    Recruiting

    Share